myelopeptide 1 has been researched along with Antibody Deficiency Syndrome in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mikhailova, AA; Petrov, RV; Shanurin, SY | 1 |
Averchenkov, VM; Fedotova, NI; Lomachenkov, VD; Meshkova, RIa | 1 |
Khabarov, AS; Kolesnikov, AP; Kozlov, VA | 1 |
Komponiec, NA; Mikhailova, AA; Sorokin, SV | 1 |
Koval'chuk, LV; Stepanenko, RN; Vlasenko, RIa | 1 |
Makhaĭlova, AA; Man'ko, VM; Osipova, EIu; Rudneva, TB | 1 |
6 other study(ies) available for myelopeptide 1 and Antibody Deficiency Syndrome
Article | Year |
---|---|
Immunoregulatory effects of two bone-marrow hexapeptides (myelopeptides) in experimental models of immunodeficiency.
Topics: Adjuvants, Immunologic; Amino Acid Sequence; Animals; Antibody Formation; B-Lymphocytes; Cells, Cultured; Cyclophosphamide; Female; Immunoglobulin G; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred NZB; Molecular Sequence Data; Oligopeptides; Peptides; Spleen | 1995 |
[Secondary immunodeficiency and its myelopid correction in patients with infiltrative and disseminated pulmonary tuberculosis].
Topics: Activins; Adjuvants, Immunologic; Adult; Antitubercular Agents; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Immunologic Deficiency Syndromes; Middle Aged; Neutrophil Activation; Oligopeptides; Peptides; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
[Diagnosis and differentiated treatment of secondary immunodeficiencies].
Topics: Acute Disease; Adjuvants, Immunologic; Antibody Formation; Biomarkers; Bronchitis; Chronic Disease; Cytokines; Drug Combinations; Fluorescent Antibody Technique, Indirect; Homeostasis; Humans; Immunity, Cellular; Immunocompromised Host; Immunoglobulins; Immunologic Deficiency Syndromes; Immunologic Factors; Infections; Inflammation; Interferon Type I; Oligopeptides; Phagocyte Bactericidal Dysfunction; Phagocytes; Pneumonia; Recurrence; Rosette Formation; Shock, Septic; Suppuration; T-Lymphocytes; Time Factors; Virus Diseases | 2001 |
Myelopeptides effect on longevity and immunological parameters in mice with congenital immunodeficiency.
Topics: Adjuvants, Immunologic; Anemia, Macrocytic; Animals; Autoimmune Diseases; Bone Marrow; Bone Marrow Cells; Hematopoiesis; Immunologic Deficiency Syndromes; Immunologic Factors; Longevity; Lupus Erythematosus, Systemic; Mice; Mice, Mutant Strains; Oligopeptides; Peptides; Swine | 1991 |
[Regulation by myelopid of immunoglobulin production in culture of human peripheral blood lymphocytes in normal and secondary immunodeficient state].
Topics: Activins; Adjuvants, Immunologic; Bone Marrow; Cardiac Surgical Procedures; Cells, Cultured; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Immunologic Deficiency Syndromes; Lymphocytes; Oligopeptides; Peptides; Postoperative Complications | 1990 |
[Myelopeptide correction of the differentiation of hematopoietic precursor cells in mice with experimental T-immunodeficiency].
Topics: Animals; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cell Differentiation; Colony-Forming Units Assay; Drug Evaluation, Preclinical; Hematopoietic Stem Cells; Immunologic Deficiency Syndromes; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Oligopeptides; Peptides; T-Lymphocytes; Thymectomy | 1989 |